Wednesday June 15th 2011
|
|
09.30-17.00 |
 Patient meeting -
Coping with a chronic disease (more
detailed program
in Dutch)
(Location: Apple Park Hotel, Pierre de Coubertinweg 3, Maastricht) |
| |
X
Parallel session
X |
| |
09.00-10.00 |
Reception with coffee and tea and
Registration NVALT meeting ‘Multidisciplinary management of chronic
pulmonary diseases’ (Location: Derlon Theatre, Plein 1992, Maastricht) |
|
10.00-12.45 |
 Multidisciplinary
management of chronic pulmonary diseases (NVALT meeting) |
| |
|
Chairs: Dr. Herman-Jan Pennings (CV),
Laurentius Hospital, Roermond, NL, Secretary
NVALT,
Dr. Yvonne
Heijdra (CV), Radboud University Nijmegen Medical Centre, Nijmegen NL,
elected secretary NVALT |
| |
10.00-10.30 |
 Benefits
of a multidisciplinary approach of sarcoidosis patients
Prof. dr. Marjolein Drent (CV),
MUMC+, NL |
| |
10.30-11.00 |
Management of IPF
Prof. dr. Ulrich Costabel (CV), Ruhrlandklinik, Essen, Germany. |
| |
11.30-12.00 |
Management of PHT in ild
Bob Baughman (CV),
Professor of Medicine, University of Cincinnati, Ohio, USA |
| |
12.00-12.30 |
Management
of asthma and COPD, let’s roll!
Prof. dr. Geert Jan Wesseling (CV),
MUMC+, NL |
| |
12.30-13.30 |
Lunch Break |
| |
13.30-16.00 |
NVALT program |
| |
 
Location:
The DerlonTheater
(previous ‘Bordenhal’).
For this occasion called:
‘LONG THEATER’
Plein 1992 nr 15
6221 JP Maastricht
|
| |
16.00-17.30 |
Registration
for WASOGBAL 2011 attendees on site (IMPORTANT: Please ensure you have a printed copy of the
confirmation of your registration and payment with you). |
|
17.30-19.30 |
Opening ceremony City
Hall Maastricht (Markt 78, Maastricht)
|
|
17.30-18.00 |
Reception |
| |
18.15-18.15 |
Welcome
Prof. dr. Marjolein Drent (CV), MUMC, UM, Maastricht, NL, vice
president WASOG |
| |
18.15-18.20 |
Opening
Onno Hoes (CV), mayor of Maastricht |
| |
18.20-18.30 |
Welcome on behalf of the
Maastricht University, NL
Prof. dr. mr. Gerard P.M.F. Mols (CV), Rector magnificus, UM, Maastricht, NL
|
| |
18.30-18.40 |
Welcome by Prof. dr. Ulrich Costabel (CV),
president of WASOG |
| |
18.40-18.45 |
‘Living with pulmonary fibrosis’
Jenny Penders, one of the founders of the
Dutch Pulmonary Fibrosis
Society |
| |
18.45-18.55 |
Welcome by André Rieu, ambassador ild care foundation |
| |
18.55-19.00 |
Congress song ‘Inspiration’ by Brigitte Heitzer |
| |
19.00-19.30 |
Reception
Please find
directions and more detailed information on our social program
here! |
|
|
|
Thursday June 16th 2011
|
|
08.30-10.30 |
Mechanisms in sarcoidosis: an update |
| |
|
Chairs: Prof. dr. Joachim Muller-Quernheim (CV),
Freiburg, Germany and
Prof. dr. Roland .M. du Bois (CV), London, UK. |
| |
08.30-09.00 |
Genetics in sarcoidosis: where do we stand?
Prof. dr. Joachim Muller-Quernheim (CV),
Freiburg, Germany |
| |
09.00-09.30 |
Is sarcoidosis an occupational disease?
Inorganic triggers involved in
the pathogenesis of granuloma formation
Prof. dr. Lee S. Newman (CV),
MD, MA, Denver Colorado, USA. |
| |
09.30-10.00 |
The
role infectious agents in de development of sarcoidosis
Dr. Wonder Puryear Drake (CV), Vanderbilt University School of Medicine,
Nashville, Tennessee, USA |
| |
10.00-10.30 |
Development in sarcoidosis treatment: new therapeutic options
Bob Baughman (CV),
Professor of Medicine, University of Cincinnati, Ohio, USA |
| |
This session is supported by the NRS
 |
|
10.30-11.00 |
Coffee break and preview posters |
|
11.00-12.30 |
Diagnostics
in interstitial lung diseases: present and future |
| |
|
Chairs: Prof. dr. Juan Mana (CV), Barcelona, Spain and
Prof. dr. Jan C. Grutters (CV),
Dept. of Respiratory Medicine, St. Antonius Hospital, Nieuwegein, UMC
Utrecht, NL |
| |
11.00-11.30 |
HRCT
scanning in sarcoidosis and other interstitial lung diseases
Prof. dr. Johny Verschakelen (CV), Dept. Radiology, University Hospital
Gasthuisberg,
Leuven, Belgium |
| |
11.30-12.00 |
Usefulness
of PET/CT scan in sarcoidosis and other interstitial lung diseases
Dr. Marinus J. van Kroonenburgh (CV),
Dept. of Nuclear Medicine, MUMC+,
Maastricht, NL |
| |
12.00-12.30 |
Is there still a role for BAL in inflammatory lung diseases?
Dr. Kitty Linssen (CV),
Dept. Medical Microbiology, MUMC, Maastricht, Netherlands |
|
X
Parallel session
X |
|
11.00-12.30 |
Management and prevention in clinical practice: role for e-health? |
| |
|
Chairs: Roger van Boxtel (CV),
CEO Menzis, Netherlands, and Prof. dr. Lee S. Newman (CV),
MD, MA, Denver Colorado, USA |
| |
11.00-11.30 |
Powering healthcare innovation
Roger van Boxtel (CV),
CEO Menzis |
| |
11.30-12.00 |
Personalized prevention: philosophy or reality?
Dr. Roderik A.
Kraaijenhagen (CV), cardiologist, Medical director, NDDO Institute for
Prevention and Early Diagnostics (NIPED) |
| |
12.00-12.30 |
Interactive case presentation
Prof .dr. Lizy Fireman (CV),
Professor of Occupational and Environmental Medicine in the Tel Aviv
University, Israel
Introduction by Dr. Benoit Wesly (CV),
honorary consul of the State of Israel |
|
12.30-13.30 |
17th
Executive Committee Meeting WASOG |
| |
|
Agenda
 |
|
X
Parallel session
X |
|
12.30-13.30 |
Lunch break and preview posters |
|
X
Parallel session
X |
|
12.30-13.00 |
Meet
the professor - The clinical utility of BAL cellular analysis in ild: an
international consensus statement - Prof. dr. Keith C. Meyer (CV),
Wisconsin, USA |
| |
This session is supported by the NRS
|
|
13.00-15.00 |
B cell depleting therapies, past, present and future concepts |
| |
|
Chairs: Prof. dr. Bob Baughman (CV),
MD, Cincinnati, USA and dr. Nadera J Sweiss (CV), Rheumatologist, Chicago, USA |
| |
13.00-13.20 |
B cell biology in the integrated immune response
Prof. dr. Jan-Willem Cohen Tervaert (CV),
Maastricht, NL |
| |
13.20-13.40 |
Rituximab administration: the basics of delivery and monitoring, lessons
learned from oncology.
Dr. Elyse Lower (CV),
Cincinnati, USA |
| |
13.40-14.00 |
Rituximab
for ANCA-associated Vasculitis
Prof. dr. Ulrich Specks (CV), Mayo Clinic, Rochester, USA |
| |
14.00-14.20 |
Rituximab
in rheumatoid arthritis, vasculitis and resistant cases with SLE.
Dr. Tim Jansen (CV), rheumatologist, Nijmegen, the Netherlands |
| |
14.20-14.40 |
Rationale for B cell depleting therapy in sarcoidosis, the impact of B
cell
depleting therapy on humiral immunity and vaccine response.
Dr. Nadera J. Sweiss (CV),
rheumatologist, Chicago, USA. |
| |
14.40-15.00 |
Discussion |
| |
Objectives:
Review advances in molecular biology that enhance our understanding of
B-cells in the integrated immune response;
Summarize the past and current clinical data relating to the usage of
B-cell-directed therapies for, Lymphoma, ANCA associated vasculitis, SLE
and rheumatoid arthritis;
Discuss the monitoring for B cell depleting therapies;
Discuss the rationale for B cell depleting therapy in Sarcoidosis, the
impact of B cell depleting therapy on humiral immunity and vaccine
response. |
|
X
Parallel session
X |
|
13.30-14.30 |
New insights in drug-induced lung
diseases |
| |
|
Chairs: Prof. dr. Olof Selroos (CV),
Vejbystrand, Sweden and Prof. Dominique
Israël-Biet (CV), Faculté de Médecine
Paris Descartes, Hôpital Européen Georges Pompidou. Paris, France |
| |
13.30-14.00 |
Pharmacogenomics and drug-induced toxicity.
Prof. dr. Aalt Bast (CV),
Department of Pharmacology and Toxicology, UM,
Maastricht, NL. |
| |
14.00-14.30 |
Drug-induced pulmonary toxicity. A still
growing and underestimated clinical problem.
Prof. dr. Philippe Camus, Professor of Pulmonary Medicine, Department
of Pulmonary and Critical Care Medicine, Hospital du Bocage and
University de Bourgogne, Dijon, France. |
|
X
Parallel session
X |
|
14.30-15.30 |
Poster
Discussion (sessions A, C, E, G) |
| |
|
A
- Case series and case reports
Chairs: Prof. dr. Venerino Poletti (CV),
Forli, Italy and Prof. dr. Marc Judson (CV),
NY, USA |
| |
|
C
- Diagnostic tools in sarcoidosis: What is
new?
Chairs: Dr. Mariunus J. van Kroonenburgh (CV), Dept. of Nuclear Medicine,
MUMC+,
Maastricht, NL and Prof. dr. Johny Verschakelen (CV), Dept. Radiology,
University Hospital
Gasthuisberg,
Leuven, Belgium |
| |
|
E
- Impact of Sarcoidosis in patients' lives
Chairs: Dr. Dan Culver (CV),
Cleveland Clinic in Cleveland, Ohio, USA and
Dr. Elske Hoitsma (CV),
Dept of Neurology, Diaconessenhuis, Leiden, NL |
| |
|
G
- Inflammation: Serum, BAL, and induced
sputum in sarcoidosis
Chairs: Dr. Kitty Linssen (CV),
Department of Medical Microbiology, MUMC+,
Maastricht, NL and Dr. Wonder Puryear Drake (CV), Vanderbilt University
School of Medicine,
Nashville, Tennessee, USA |
|
X
Parallel session
X |
|
15.00-16.30 |
Bone
sarcoidosis and osteoporosis prevention in sarcoidosis |
| |
|
Chairs: Dr. Tim L. Jansen (CV),
Dept. of Rheumatology, UMCN St. Radboud, Nijmegen, NL and Dr.
Marinus J. van Kroonenburgh, Dept. of Nuclear
Medicine, MUMC+, Maastricht, NL |
| |
15.00-15.30 |
Bone sarcoidosis
Prof. dr. Piet Geusens, Rheumatologist, MUMC+, Maastricht, NL |
| |
15.30-16.00 |
Fracture risk in sarcoidosis
Dr. Caroline. Heijckmann (CV),Bernoven Hospital, Veghel, NL |
| |
16.00-16.30 |
Prevention of fractures and osteoporosis in sarcoidosis
Dr. Joop van den Bergh (CV),
VieCuri Medical Centre Noord-Limburg & MUMC, NL |
|
X
Parallel session
X |
|
15.00-16.30 |
Oral presentations
(abstracts) |
| |
|
Chairs: Prof. dr. Ron M. du Bois (CV), London UK
and Dr. Wonder Puryear Drake (CV), Vanderbilt University School of Medicine,
Nashville, Tennessee, USA |
| |
15.00-15.10 |
O1 - GWAS in Japanese patients with
sarcoidosis by the use of pooled samples
Dr. E. Yamaguchi (CV), Division of Respiratory Medicine and Allergology, Dept
of Medicine, Aichi Medical University School of Medicine, Japan |
| |
15.10-15.20 |
O2 - Two novel ways for distinguishing
sarcoidosis from sputum negative tuberculosis
H.P. Li (CV), Dept of Respiratory Medicine, Shanghai Pulmonary Hospital,
Tongji University School of Medicine, China |
| |
15.20-15.30 |
O3 - Reduced expression of PPARα in
bronchoalveolar lavage CD4+ T cells of sarcoidosis patients
M. Abo Al Hayja (CV),
Respiratory Medicine Unit, Department of Medicine, Solna, Karolinska
Institutet, Sweden |
| |
15.30-15.40 |
O4 - Increased local and circulating T
helper 17 cells in pulmonary sarcoidosis
B. ten Berge (CV),
Dept of Pulmonary Medicine, Erasmus MC Rotterdam, The Netherlands |
| |
15.40-15.50 |
O5 - Impaired gas exchange, exercise
capacity, and muscle strength in sarcoidosis patients
R.G.J. Marcellis (CV), Dept of Physical Therapy, ild care team, Maastricht
University Medical Centre, the Netherlands |
| |
15.50-16.00 |
O6 - The clinical course of sarcoidosis:
Description and treatment response in a large American cohort
M.A. Judson (CV),
Division of Pulmonary and Critical Care Medicine, Medical University of
South Carolina, USA |
| |
16.00-16.10 |
O7 - Imbalance between circulating
endothelial cells and endothelial progenitors in idiopathic pulmonary
fibrosis
Prof. Dominique Israël-Biet, Faculté de Médecine Paris Descartes,
Hôpital Européen Georges Pompidou. Paris, France |
| |
16.10-16.20 |
O8 - Mutations in SFTPC, SFTPA2 and TERT
explain 60% of Familial Pulmonary Fibrosis and correlate to specific
disease phenotypes
C.H.M. van Moorsel (CV), Center for Interstitial Lung Disease, St Antonius
Hospital, the Netherlands |
| |
16.20-16.30 |
Discussion
The announcement of 4 Award Winners will take place during the
congress
party Friday June the 17th around 21.30h. |
|
X
Parallel session
X |
|
15.30-16.30 |
Poster
Discussion (sessions B, D, F, H) |
| |
|
B
- Genetics and mechanisms in sarcoidosis
Chairs: Prof. dr. Jan C. Grutters (CV),
Dept. of Respiratory Medicine, St. Antonius
Hospital, Nieuwegein, UMC
Utrecht, NL and Prof. dr. Joachim Muller-Quernheim (CV),
Freiburg, Germany |
| |
|
D
- Treatment options in sarcoidosis
Chairs: Prof. dr. Bob Baughman (CV),
MD, Cincinnati, USA and Prof. dr. Wim
Wuyts (CV), Dept. of Respiratory Medicine, University Hospital Gasthuisberg,
Leuven,
Belgium |
| |
|
F
- Pulmonary fibrosis and other ild
Chairs: Prof. dr. M. Thomeer (CV),
Hospitals Oost-Limburg, Genk/ University
Hospital Leuven, Belgium and Dr.Özlem Özdemir Kumbasar (CV), Ankara, Turkey |
| |
|
H
- Inflammation: Serum, BAL, and induced
sputum in ild
Chairs: Dr. Karin Boomars, Dept of Respiratory Medicine, MUMC+, NL and
Dr. Francesco Bonella (CV),
Ruhrlandklinik, Essen, Germany |
|
16.30-17.00 |
Coffee break |
|
17.00-19.00 |
Idiopathic
pulmonary fibrosis: how should we treat it? |
| |
|
Chairs: Prof. dr. Venerino Poletti (CV),
Forli, Italy and Prof. dr. Ulrich
Costabel (CV),
Ruhrlandklinik, Essen, Germany |
| |
17.00-17.20 |
Clinical trials in IPF: how to choose appropriate end-points?
Prof. dr. Ron M. du Bois (CV), London UK
|
| |
17.20-17.45 |
IPF: pathogenesis and mechanisms
Prof. dr. Jan C. Grutters (CV), Dept. of Respiratory Medicine, St.
Antonius Hospital, Nieuwegein, UMC Utrecht, NL. |
| |
17.45-18.10 |
The evidence of pharmaceutical therapy in IPF
Dr. Paolo Spagnolo (CV),
Paolo Spagnolo MD, PhD, lecturer in Respiratory
Medicine, University of Modena and Reggio Emilia, Modena, Italy
|
| |
18.10-18.35 |
New approaches to IPF treatment
Prof. dr. Ulrich Costabel (CV), Ruhrlandklinik, Essen, Germany. |
| |
18.35-18.50 |
Non-medical treatment of IPF
Prof. dr. Jim Egan (CV),
Mater Hospital, Dublin, Ireland. |
|
|
|
Friday June 17th 2011
|
|
08.30-10.30 |
Impact
of sarcoidosis on patients lives |
| |
|
Chairs: Prof .dr. Tetsuo Yamaguchi (CV),Tokyo,
Japan and Dr. Dan Culver (CV),
Cleveland Clinic in Cleveland, Ohio, USA and Dr. Tony Cerami (CV) |
| |
08.30-09.00 |
Quality of life in interstitial lung diseases: how should we deal with
it?
Prof. dr. Jolanda De Vries (CV), Depts. of Medical Psychology, CoRPS,
Tilburg University,
and St. Elisabeth Hospital, Tilburg, NL. |
| |
09.00-09.30 |
Everyday cognitive failure in sarcoidosis
Dr. Rudolf Ponds (CV), Depts. of Psychiatry and Psychology, MUMC,
Maastricht, NL. |
| |
09.30-10.00 |
How should we deal with fatigue in sarcoidosis: diagnosis and treatment
Dr. Elyse Lower (CV), Dept. of Internal Medicine, University of Cincinnati
Medical
Center,
Cincinnati, USA. |
| |
10.00-10.30 |
Small fiber neuropathy and autonomic dysfunction: diagnosis and
treatment
Dr. Elske Hoitsma (CV), Dept of Neurology, Diaconessenhuis, Leiden, NL. |
|
X
Parallel session
X |
|
09.00-10.30 |
Cystic Fibrosis: an update |
| |
|
Chairs: Dr. Han Hendriks (CV), Maastricht, NL
and
Dr. Wonder Drake (CV),
Nashville, Tennessee, USA |
| |
09.00-09.30 |
Microbiology in Cystic Fibrosis: host
pathogen interaction
Prof. Dr. Gerd Döring (CV), Institut für Medizinische Mikrobiologie
und
Hygiene, Tübingen, Germany |
| |
09.30-10.00 |
Treatment of Pseudomonas aeruginosa lung
infections in Cystic Fibrosis
Dr. Harry Heijerman (CV),
Den Haag, the Netherlands |
| |
10.00-10.30 |
How to repair chloride transport in Cystic
Fibrosis?
Prof. dr. Kors van der Ent (CV),
Utrecht, the Netherlands |
| |
sponsored
by
 |
|
X
Parallel session
X |
|
08.30-10.30 |
Granulomatous
diseases in the eye: risk of intraocular damage and vision loss |
| |
|
Chairs: Prof. dr. Martin van Hagen (CV),
Dept. of Immunology, Eramus Medical Centre,
Rotterdam, NL and Dr. Roel Erckens (CV),
Dept. Ophthalmonology, ild care team, MUMC, Maastricht, NL |
| |
08.30-09.00 |
When
sarcoidosis meets the eye
Dr. G.S. Baarsma (CV),
the Rotterdam Eye Hospital, Rotterdam, NL |
| |
09.00-09.30 |
Granulomatous uveitis: not always sarcoidosis.
Dr. J.G. Bollemeijer (CV), Dept. of Ophthalmonology, Leiden University
Medical Centre (LUMC), Leiden, NL. |
| |
09.30-10.00 |
Biologicals in granulomatous diseases and uveitis.
Prof. dr. M. van Hagen (CV),
Dept. of Immunology, Eramus Medical Centre,
Rotterdam, NL |
| |
10.00-10.30 |
How to treat destructive granulomatous eye diseases?
Dr. R. Erckens (CV),
Dept. Ophthalmonology, ild care team, MUMC, Maastricht, NL |
|
10.30-11.00 |
Coffee break |
|
11.00-12.30 |
Everything you need to know about biologicals |
| |
|
Chairs: Dr. Tim L. Jansen (CV),
Dept. of Rheumatology, UMCN St. Radboud, Nijmegen, NL
and Bob Baughman (CV), Professor of Medicine, University of Cincinnati,
Ohio, USA |
| |
11.00-11.30 |
Biologicals: What is new?
Prof. dr. Jan G.J. van de Winkel (CV),
Dept. of Immunology, UMC Utrecht,
Netherlands
|
| |
11.30-12.00 |
The
role of biologicals in emerging infections
Prof. dr. Roel Coutinho (CV),
RIVM, Bilthoven, Netherlands |
| |
12.00-12.30 |
Biologicals:
how can we cover the costs?
Drs. Bart van der Lelie (CV),
Reimbursement Expert, Netherlands. |
|
12.30-13.30 |
Lunch break and poster viewing |
|
X
Parallel session
X |
|
12.30-13.30 |
Meeting
General Assembly WASOG |
| |
|
Agenda
Every
member is invited to read the new by-laws in advance before the
presentation for approval in Maastricht.
|
|
13.30-15.00 |
Breathtaking
exposures: Role of environmental and occupational exposures in ild |
| |
|
Chairs: Prof. dr. Lee S. Newman (CV),
Professor of Environmental and Occupational Health, Colorado School of
Public Health and School of Medicine University of Colorado, Aurora,
Colorado, USA and
Prof.dr. Onno van Schayck (CV),
Maastricht, NL |
| |
13.30-14.00 |
Particles and radicals
Prof. dr. Aalt Bast (CV), Department of Pharmacology and Toxicology,
UM,
Maastricht, NL. |
| |
14.00-14.30 |
Old and novel industrial products as causes
of interstitial lung diseases
Prof. dr. Benoit Nemery (CV), MD, PhD, Professor of Toxicology &
Occupational
Medicine,
KU Leuven |
| |
14.30-15.00 |
From birds to fungi: extrinsic allergic alveolitis
Prof. dr. Ulrich Costabel (CV),
Ruhrlandklinik, Essen, Germany |
|
X
Parallel session
X |
|
13.30-15.00 |
Granulomatous
infectious disorders |
| |
|
Chairs: Dr. Kitty Linssen (CV),
Department of Medical Microbiology, MUMC+, Maastricht, Netherlands and
Prof. dr. Roel Coutinho (CV),
RIVM, Bilthoven, The Netherlands |
| |
13.30-14.00 |
Q
fever: clinical implications
Dr. Chantal Bleeker-Rovers (CV),
Department of Internal Medicine Radboud
University Nijmegen Medical Centre in Nijmegen (RUNMC), The Netherlands |
| |
14.00-14.30 |
Lyme-borreliosis
Prof. dr. Bart-Jan Kullberg (CV),
Chairman Nijmegen University Centre for
Infectious Diseases (NUCI), UMC
Nijmegen, St. Radboud, NL |
| |
14.30-15.00 |
Tuberculosis,
new diagnostic challenges and opportunities.
Dr. Aik W. J. Bossink (CV),
Dept of Respiratory Medicine, Diakonessenhuis,
Utrecht, NL |
|
15.00-15.20 |
Coffee break |
|
15.20-16.00 |
Honoured Gerry James Lecture: Is
sarcoidosis ready for personalized medicine?
Chair: Prof. dr. Lee S. Newman (CV),
MD, MA, Denver Colorado, USA
Speaker: Prof. dr. Roland M. du Bois (CV), London, UK. |
|
16.15-17.15 |
Panel discussion with world experts:
Health and environment
|
| |
|
Chair:
Prof.dr. Onno van Schayck (CV),
Maastricht, NL
Panel:
- Prof. dr. Aalt Bast (CV),
Department of Pharmacology and Toxicology, UM,
Maastricht, NL.
-
Prof. dr. Benoit Nemery (CV), Professor of Toxicology &
Occupational
Medicine,
KU Leuven
- Prof. dr. Lee S. Newman (CV),
Professor of Environmental and Occupational Health, Colorado School of
Public Health and School of Medicine University of Colorado, Aurora,
Colorado, USA
- Dr. Jos Rooijackers (CV),
NECORD, IRAS / Utrecht University and Division Heart & Lungs,
University Medical Centre Utrecht, The Netherlands
|
|
19.00-23.30 |
Conference
Party with Dinner Buffet
all
first authors of the submitted abstracts are invited!
Announcement of the 4 Award Winners |
|
|
|
Saturday June 18th 2011
|
|
08.30-10.35 |
Workshop
of endpoints for studies in sarcoidosis |
| |
|
Chairs:
prof. dr. Bob Baughman (CV), Cincinnati, USA;
Prof. dr. Marjolein
Drent (CV),
MUMC, UM, Maastricht |
| |
08.30-08.55 |
Pulmonary
Chair Prof. dr. Dominic Valeyre (CV), MD, France; Discussants Prof. dr.
Marc Judson (CV),
NY, USA & Prof. dr. Athol Wells (CV), MD, United Kingdom |
| |
08.55-09.20 |
Pulmonary hypertension
Chair Prof. dr. T. Handa (CV), MD, Japan; Discussants Dr. Roxanne Sulica,
MD, USA &
Prof. dr. Marc Humbert (CV), MD, France |
| |
09.20-09.45 |
Fatigue
Chair Dr. Violetta Vucinic (CV), MD, Serbia; Discussant Prof. dr.
Marjolein Drent (CV), MD, Netherlands & Dr. Elyse Lower, MD, USA |
| |
09.45-10.10 |
Cutaneous
Chair Dr. Dan Culver (CV), MD, USA; Discussant Prof. dr. Robert Baughman
(CV),
MD, USA & Prof. dr. Juan Mana (CV),
MD, Spain |
| |
10.10-10.35 |
Phenotype/Genotype
Chair Dr. Carlos Pereira, MD, Brasil; Discussants Prof. dr. Jan C.
Grutters (CV),
MD, NL & Dr. Antje Prasse, MD, Germany |
| |
Workshop format: For each session, there will be 10 minutes for each
discussant and 5 minutes for general discussion. One Discussant will
present a review of trials in the area and what had been used as end
points. The other Discussant will present what the two Discussants
propose as endpoints for their organ. The Discussants and Chair will be
responsible for a report summarizing their talks and the decision of the
group. We propose to publish that report in the official journal of
WASOG: Sarcoidosis Vasculitis and Diffuse Lung Diseases. |
|
X
Parallel session
X |
|
09.00-10.30 |
Lung
transplantation: where are we now, where are we going to? |
| |
|
Chairs: Prof. dr. Keith Meyer (CV),
Dept. of Medicine at the University of Wisconsin, USA;
Dr. B. van den Blink (CV),
Dept. of Respiratory Medicine, Erasmus UMC Rotterdam, NL |
| |
09.00-09.30 |
How to overcome donor shortage? Are DCD
donors the real solution?
Dr. Michiel Erasmus (CV),
Groningen, NL |
| |
09.30-10.00 |
Transplantation
anno 2011: Indications, results and expectations
Dr. Andrew Fisher (CV),
Newcastle, UK |
| |
10.00-10.30 |
Infectious and rejection problems after lung transplantation: can we
treat them?
Prof. dr. Geert Verleden (CV), Gashuisberg, University Hospital, Leuven,
Belgium |
|
10.30-11.00 |
Coffee break |
|
11.00-12.30 |
Vasculitis and pulmonary hypertension in
ild |
| |
|
Chairs: prof. dr. Jan-Willem Cohen
Tervaert (CV), Maastricht, NL and
prof. dr. Bob Baughman (CV), Cincinnati, USA |
| |
11.00-11.30 |
Vasculitis
and Wegener’s disease related ild
Prof. dr. Ulrich Specks (CV),
Mayo Clinic and Foundation, Rochester, USA
|
| |
11.30-12.00 |
Pulmonary hypertension in ild: increased
mortality risk
Prof. dr. Marc Humbert (CV), Paris, France |
| |
12.00-12.30 |
Treatment options of PHT in ild
Prof. dr. Anton Vonk Noordegraaf (CV), Amsterdam, NL
|
|
12.30-13.30 |
Lunch break |
| |
12.30-13.15 |
Sarcoidosis Vasc Diffuse Lung Dis
Journal Editorial Board meeting |
|
13.30-15.00 |
Closure
session |
| |
|
Chairs: Prof. dr. Ulrich Costabel (CV), Ruhrlandklinik, Essen, Germany.
Prof. dr. Marjolein Drent (CV),
MUMC+, NL |
| |
13.30-14.00 |
BAL:
perspective from the 12th BAL conference and the 2nd joint
WASOGBAL meeting. Prof. dr. Herbert Reynolds (CV),
USA |
| |
14.00-14.30 |
Sarcoidosis: perspective from the 10th WASOG meeting and future plans
Prof. dr. Marc Judson (CV),
NY, USA |
| |
14.30-15.00 |
Final closure & announcement next conference in 2014 Turkey |